Patents by Inventor Sven MOOSMANG

Sven MOOSMANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DAPAGLIFLOZIN AND AMBRISENTAN FOR THE PREVENTION AND TREATMENT OF COVID-19
    Publication number: 20230165856
    Abstract: The present disclosure is directed to the use of dapagliflozin and ambrisentan for the treatment and prevention of coronavirus disease 2019 (COVID-19), SARS-CoV-2 infection, and/or symptoms thereof.
    Type: Application
    Filed: April 28, 2021
    Publication date: June 1, 2023
    Inventors: Philip AMBERY, Peter GREASLEY, Sven MOOSMANG, Magnus ALTHAGE